A five-year epidemiologic study of autoimmune bullous diseases in Southeast of Iran
Abstract
Abstract Background Autoimmune bullous diseases (AIBDs) are a group of chronic blistering diseases that affect mucocutaneous membranes. These diseases are common worldwide and affect males and females of all races. Treatment options include corticosteroids, rituximab, and topical agents. We evaluated the epidemiology of AIBD in Kerman, Iran, over a five-year period. Methods This retrospective study was conducted on 100 patients diagnosed with an AIBD between 2015–2020. All patients were included in this study by census method. Factors like age, sex, disease type, and age at diagnosis were evaluated. Data analyses were performed using SPSS version 26. Results One hundred patients participated in this study, and the male-to-female ratio was 1:1.08. The mean age of participants was 51.99 ± 19.52 years, and the mean age at diagnosis was 49.19 ± 8.31. Out of 100 patients, 82 suffered from pemphigus disease (70 pemphigus vulgaris; 12 pemphigus foliaceus), 17 had bullous pemphigoid, and one patient had pemphigus gestationis. Conclusion In many countries, pemphigus is the most common AIBD. Although AIBDs are uncommon, the diagnosed cases increase with age.References
Chu K-Y, Yu H-S, Yu S. Current and Innovated Managements for Autoimmune Bullous Skin Disorders: An Overview. Journal of Clinical Medicine. 2022;11(12):3528.
Behkar A, Garmaroudi G, Nasimi M, Yousefi S, Khosravi H, Kianfar N, et al. Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men. International journal of women's dermatology. 2022;8(1):e004.
Rashid H, Lamberts A, Diercks GF, Pas HH, Meijer JM, Bolling MC, et al. Oral lesions in autoimmune bullous diseases: an overview of clinical characteristics and diagnostic algorithm. American journal of clinical dermatology. 2019;20(6):847-61.
Schmidt E, Borradori L, Joly P. Epidemiology of autoimmune bullous diseases. Blistering diseases: Springer; 2015. p. 251-63.
van Beek N, Zillikens D, Schmidt E. Diagnosis of autoimmune bullous diseases. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2018;16(9):1077-91.
Fagundes PPS, Santi CG, Maruta CW, Miyamoto D, Aoki V. Autoimmune bullous diseases in pregnancy: clinical and epidemiological characteristics and therapeutic approach. Anais Brasileiros de Dermatologia. 2021;96:581-90.
Heckler I, Hong M, Sinha AA, Venkataraman I. Serological Biomarkers and Their Detection in Autoimmune Bullous Skin Diseases. Dermatology Practical & Conceptual. 2022;12(2).
Song A, Lee SE, Kim JH. Immunopathology and immunotherapy of inflammatory skin diseases. Immune Network. 2022;22(1).
Kanazawa N. Designation of autoinflammatory skin manifestations with specific genetic backgrounds. Frontiers in Immunology. 2020;11:475.
Kridin K. Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations. Immunologic research. 2018;66(1):6-17.
Meurer M. Immunosuppressive therapy for autoimmune bullous diseases. Clinics in dermatology. 2012;30(1):78-83.
Schmidt E, Hunzelmann N, Zillikens D, Bröcker EB, Goebeler M. Rituximab in refractory autoimmune bullous diseases. Clinical and Experimental Dermatology: Clinical dermatology. 2006;31(4):503-8.
Abdolsamadi HR, Abdollahzadeh S, Vaziri PB, Beheshti A, Shafigh E, Vahedi M. epidemiology of pemphigus in Tehran, Iran: a 20-year retrospective study. Journal of Dental Research, Dental Clinics, Dental Prospects. 2007;1(3):108.
Sánchez-García V, Pérez-Alcaraz L, Belinchón-Romero I, Ramos-Rincón J-M. Comorbidities in Patients with Autoimmune Bullous Disorders: Hospital-Based Registry Study. Life. 2022;12(4):595.
Bickle KM, Roark TK, Hsu S. Autoimmune bullous dermatoses: a review. American family physician. 2002;65(9):1861.
Ljubojevic S, Lipozenčić J. Autoimmune bullous diseases associations. Clinics in dermatology. 2012;30(1):17-33.
Esmaili N, Hallaji Z, Soori T, Davatchi CC. Bullous pemphigoid in Iranian patients: a descriptive study on 122 cases. Acta Medica Iranica. 2012:335-8.
Balighi K, Daneshpazhooh M, Mahmoudi H, Nasimi M, Delavari A, Azizpour A. Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran. Acta Medica Iranica. 2018:522-5.
Ali A, AliReza Y, Gita F. Pemphigus vulgaris in Iran: epidemiology and clinical profile. SKINmed: Dermatology for the Clinician. 2006;5(2):69-71.
Chmurova N, Svecova D. Pemphigus vulgaris: a 11-year review. Bratisl Lek Listy. 2009;110(8):500-3.
Jowkar F, Sadat Sadati M, Tavana S, Agah MA. Epidemiology of autoimmune bullous diseases and therapeutic modalities during a 10 year period in Iran. Acta Dermatovenerologica Croatica. 2014;22(4):246-.
Daneshpazhooh M, Chams‐Davatchi C, Payandemehr P, Nassiri S, Valikhani M, Safai‐Naraghi Z. Spectrum of autoimmune bullous diseases in Iran: a 10‐year review. International journal of dermatology. 2012;51(1):35-41.
Ghiasi M, Daneshpazhooh M, Ismonov M, Chams-Davatchi C. Evaluation of Autoimmune Bullous Diseases in Elderly Patients in Iran: A 10-Year Retrospective Study. Skinmed. 2017;15(3):175-80.
Nanda A, Dvorak R, Al‐Saeed K, Al‐Sabah H, Alsaleh QA. Spectrum of autoimmune bullous diseases in Kuwait. International journal of dermatology. 2004;43(12):876-81.
ADAM BA. Bullous diseases in Malaysia: epidemiology and natural history. International journal of dermatology. 1992;31(1):42-5.
Uzun S, Durdu M, Akman A, Gunasti S, Uslular C, Memisoglu HR, et al. Pemphigus in the Mediterranean region of Turkey: a study of 148 cases. International journal of dermatology. 2006;45(5):523-8.
Baican A, Baican C, Chiriac G, Chiriac MT, Macovei V, Zillikens D, et al. Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania. Wiley Online Library; 2010.
PEIYING J, CHANGGENG S, GANYUN Y. Chronic bullous dermatoses in China. International journal of dermatology. 1993;32(2):89-92.
Bertram F, Bröcker EB, Zillikens D, Schmidt E. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2009;7(5):434-9.
Marazza G, Pham H, Schärer L, Pedrazzetti P, Hunziker T, Trüeb R, et al. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2‐year prospective study. British journal of dermatology. 2009;161(4):861-8.
Langan S, Smeeth L, Hubbard R, Fleming K, Smith C, West J. Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study. BMJ [Internet]. 2008; 337: 160–3.
Goon ATJ, Tan SH. Comparative study of pemphigus vulgaris and pemphigus foliaceus in Singapore. Australasian journal of dermatology. 2001;42(3):172-5.
Kridin K, Bergman R. Ethnic variations in the epidemiology of bullous pemphigoid in Israel. International journal of dermatology. 2018;57(1):34-9.
Kridin K, Zelber-Sagi S, Khamaisi M, Cohen AD, Bergman R. Remarkable differences in the epidemiology of pemphigus among two ethnic populations in the same geographic region. Journal of the American Academy of Dermatology. 2016;75(5):925-30.
Langan S, Smeeth L, Hubbard R, Fleming K, Smith C, West J. Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study. Bmj. 2008;337.
Zaraa I, Kerkeni N, Ishak F, Zribi H, El Euch D, Mokni M, et al. Spectrum of autoimmune blistering dermatoses in Tunisia: an 11‐year study and a review of the literature. International journal of dermatology. 2011;50(8):939-44.
Tallab T, Joharji H, Bahamdan K, Karkashan E, Mourad M, Ibrahim K. The incidence of pemphigus in the southern region of Saudi Arabia. International journal of dermatology. 2001;40(9):570-2.
Kanwar AJ. Dipankar De. Pemphigus in India Indian Journal of Dermatology, Venereology and Leprology. 2011;77(4):439-49.
Bastuji-Garin S, Souissi R, Blum L, Turki H, Nouira R, Jomaa B, et al. Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women. Journal of investigative dermatology. 1995;104(2):302-5.
Barton L, BUTTERBACH‐BAHL K, Kiese R, Murphy DV. Nitrous oxide fluxes from a grain–legume crop (narrow‐leafed lupin) grown in a semiarid climate. Global Change Biology. 2011;17(2):1153-66.
Seo PG, Choi WW, Chung JH. Pemphigus in Korea: clinical manifestations and treatment protocol. The Journal of Dermatology. 2003;30(11):782-8.
Amin MN, Islam AM. Clinical, histologic and immunologic features of pemphigus in Bangladesh. International journal of dermatology. 2006;45(11):1317-8.
Tsankov N, Vassileva S, Kamarashev J, Kazandjieva J, Kuzeva V. Epidemiology of pemphigus in Sofia, Bulgaria. A 16‐year retrospective study (1980–1995). International journal of dermatology. 2000;39(2):104-8.
Golušin Z, Poljački M, Jovanoviç M, Ðuran V, Stojanoviç S, Rajiç N. Some epidemiological features of pemphigus chronicus in South Vojvodina: a 12‐year retrospective study. International journal of dermatology. 2005;44(9):792-3.
Kyriakis K, Tosca A, Lehou J, Hatzis J, Vareltzidis A, Stratigos J. A five year retrospective study on pemphigus and pemphigoid. Australasian journal of dermatology. 1989;30(1):33-6.
Coronel-Pérez IM, Rodríguez-Rey E, Pérez-Bernal A, Camacho F. Epidemiology of pemphigus in hospital universitario virgen macarena, seville, spain, 2005-2006. Actas Dermo-Sifiliográficas (English Edition). 2009;100(2):121-5.
Wilson C, Wojnarowska F, Mehra N, Pasricha J. Pemphigus in Oxford, UK, and New Delhi, India: a comparative study of disease characteristics and HLA antigens. Dermatology. 1994;189(Suppl. 1):108-10.
Chiossi MPdV, Roselino AMF. Endemic pemphigus foliaceus (" fogo selvagem"): A series from the Northeastern region of the state of São Paulo, Brazil, 1973-1998. Revista do Instituto de Medicina Tropical de São Paulo. 2001;43:59-62.
Mahe A, Flageul B, Cisse I, Keita S, Bobin P. Pmphigus in Mali: a study of 30 cases. British Journal of Dermatology. 1996;134(1):114-9.
Aboobaker J, Morar N, Ramdial PK, Hammond MG. Pemphigus in South Africa. International journal of dermatology. 2001;40(2):115-9.
Hietanen J, Salo O. Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978. Acta dermato-venereologica. 1982;62(6):491-6.
Chacón GR, Ortega‐Loayza AG, Cyr RM. Historical notes on endemic pemphigus in South America. International Journal of Dermatology. 2012;51(4):477-81.
Micali MD G, Musumeci MD M, Letizia, Nasca MD MR. Epidemiologic analysis and clinical course of 84 consecutive cases of pemphigus in eastern Sicily. International journal of dermatology. 1998;37(3):197-200.
Suliman NM, Åstrøm AN, Ali RW, Salman H, Johannessen AC. Clinical and histological characterization of oral pemphigus lesions in patients with skin diseases: a cross sectional study from Sudan. BMC oral health. 2013;13(1):1-12.
Kavala M, Zindancı İ, Turkoglu Z, Kuru B, Ozlu E, Simsek M. Nineteen-year retrospective evaluation of pemphigus in a single dermatology centre in Istanbul, Turkey. Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii. 2020;37(1):23-8.
Svecova D. Pemphigus vulgaris: a clinical study of 44 cases over a 20‐year period. International Journal of Dermatology. 2015;54(10):1138-44.
Javidi Z, Meibodi NT, Nahidi Y. Epidemiology of pemphigus in northeast Iran: A 10-year retrospective study. Indian Journal of Dermatology. 2007;52(4):188.
España A, Fernández S, Del Olmo J, Marquina M, Pretel M, Ruba D, et al. Ear, nose and throat manifestations in pemphigus vulgaris. British Journal of Dermatology. 2007;156(4):733-7.
GONÇALO RIC, SEVERO MLB, MEDEIROS AMCd, OLIVEIRA PTd, SILVEIRA ÉJDD. Vesiculobullous autoimmune diseases with oral mucosa manifestations: retrospective and follow-up study. RGO-Revista Gaúcha de Odontologia. 2018;66:42-9.
Guliani A, De D, Handa S, Mahajan R, Sachdeva N, Radotra BD, et al. Identification of clinical and immunological factors associated with clinical relapse of pemphigus vulgaris in remission. Indian Journal of Dermatology, Venereology and Leprology. 2020;86:233.
Fawzy MM, Hegazy RA, Abdel Fattah AF. Ear, nose, and throat involvement in E gyptian patients with pemphigus vulgaris: a step towards a better management. International Journal of Dermatology. 2013;52(10):1268-73.
Michailidou EZ, Belazi MA, Markopoulos AK, Tsatsos MI, Mourellou ON, Antoniades DZ. Epidemiologic survey of pemphigus vulgaris with oral manifestations in northern Greece: retrospective study of 129 patients. International journal of dermatology. 2007;46(4):356-61.
Arduino PG, Broccoletti R, Carbone M, Gambino A, Sciannameo V, Conrotto D, et al. Long‐term evaluation of pemphigus vulgaris: A retrospective consideration of 98 patients treated in an oral medicine unit in north‐west Italy. Journal of Oral Pathology & Medicine. 2019;48(5):406-12.
Calabria E, Fortuna G, Aria M, Mignogna MD. Autoimmune mucocutaneous blistering diseases in the south of Italy: a 25‐year retrospective study on 169 patients. Journal of Oral Pathology & Medicine. 2020;49(7):672-80.
Chiu Y-W, Chen Y-D, Hua T-C, Wu C-H, Liu H-N, Chang Y-T. Comorbid autoimmune diseases in patients with pemphigus: a nationwide case-control study in Taiwan. European Journal of Dermatology. 2017;27(4):375-81.
Askin O, Ozkoca D, Kutlubay Z, Mat MC. A retrospective analysis of pemphigus vulgaris patients: Demographics, diagnosis, co-morbid diseases and treatment modalities used. Northern Clinics of İstanbul. 2020;7(6):597.
Heelan K, Mahar A, Walsh S, Shear N. Pemphigus and associated comorbidities: a cross‐sectional study. Clinical and Experimental Dermatology. 2015;40(6):593-9.
Wong S, Chua S. Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2‐year review. British Journal of Dermatology. 2002;147(3):476-80.
Zillikens D, Wever S, Roth A, Weidenthaler-Barth B, Hashimoto T, Bröcker E-B. Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Archives of dermatology. 1995;131(8):957-8.
Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux J-P, et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Archives of dermatology. 1995;131(1):48-52.
Garred P, Brygge K, Sørensen C, Madsen H, Thiel S, Svejgaard A. Mannan-binding protein—levels in plasma and upper-airways secretions and frequency of genotypes in children with recurrence of otitis media. Clinical & Experimental Immunology. 1993;94(1):99-104.
Junga M, Kippesb W, Messer G, Zillikens D, Rzany B. Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. Journal of the American Academy of Dermatology. 1999;41(2):266-8.
Parker SR, Dyson S, Brisman S, Pennie M, Swerlick RA, Khan R, et al. Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States. Journal of the American Academy of Dermatology. 2008;59(4):582-8.
Cai S, Allen J, Lim Y, Chua S, Tan S, Tang M. Mortality of bullous pemphigoid in S ingapore: risk factors and causes of death in 359 patients seen at the N ational S kin C entre. British Journal of Dermatology. 2014;170(6):1319-26.
Clapé A, Muller C, Gatouillat G, Le Jan S, Barbe C, Pham B-N, et al. Mucosal involvement in bullous pemphigoid is mostly associated with disease severity and to absence of anti-BP230 autoantibody. Frontiers in Immunology. 2018;9:479.
Della Torre R, Combescure C, Cortés B, Marazza G, Beltraminelli H, Naldi L, et al. Clinical presentation and diagnostic delay in bullous pemphigoid: a prospective nationwide cohort. British journal of dermatology. 2012;167(5):1111-7.
Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, et al. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clinical Immunology. 2008;128(3):415-26.
Kridin K, Bergman R. Assessment of the prevalence of mucosal involvement in bullous pemphigoid. JAMA dermatology. 2019;155(2):166-71.
Banihashemi M, Zabolinejad N, Vahabi S, Razavi HS. Survey of bullous pemphigoid disease in northern Iran. International Journal of Dermatology. 2015;54(11):1246-9.
Kibsgaard L, Rasmussen M, Lamberg A, Deleuran M, Olesen A, Vestergaard C. Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population‐based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid. British Journal of Dermatology. 2017;176(6):1486-91.
Försti AK, Huilaja L, Schmidt E, Tasanen K. Neurological and psychiatric associations in bullous pemphigoid—more than skin deep? Experimental dermatology. 2017;26(12):1228-34.
Lee S, Rastogi S, Hsu DY, Nardone B, Silverberg JI. Association of bullous pemphigoid and comorbid health conditions: a case–control study. Archives of Dermatological Research. 2021;313(5):327-32.
Bech R, Kibsgaard L, Vestergaard C. Comorbidities and treatment strategies in bullous pemphigoid: an appraisal of the existing litterature. Frontiers in medicine. 2018;5:238.
Jeon HW, Yun SJ, Lee S-C, Won YH, Lee J-B. Mortality and comorbidity profiles of patients with bullous pemphigoid in Korea. Annals of Dermatology. 2018;30(1):13-9.
Chen Y-J, Juan C-K, Chang Y-T, Wu C-Y, Ho HJ, Tseng H-C. Association between inflammatory bowel disease and bullous pemphigoid: a population-based case–control study. Scientific reports. 2020;10(1):1-7.
